285 related articles for article (PubMed ID: 18562811)
21. Statin-associated myopathy.
Thompson PD; Clarkson P; Karas RH
JAMA; 2003 Apr; 289(13):1681-90. PubMed ID: 12672737
[TBL] [Abstract][Full Text] [Related]
22. Statin drug interactions and related adverse reactions.
Bellosta S; Corsini A
Expert Opin Drug Saf; 2012 Nov; 11(6):933-46. PubMed ID: 22866966
[TBL] [Abstract][Full Text] [Related]
23. Effects of HMG-CoA reductase inhibitors on skeletal muscle: are all statins the same?
Evans M; Rees A
Drug Saf; 2002; 25(9):649-63. PubMed ID: 12137559
[TBL] [Abstract][Full Text] [Related]
24. Does simvastatin cause more myotoxicity compared with other statins?
Backes JM; Howard PA; Ruisinger JF; Moriarty PM
Ann Pharmacother; 2009 Dec; 43(12):2012-20. PubMed ID: 19920157
[TBL] [Abstract][Full Text] [Related]
25. Risk for myopathy with statin therapy in high-risk patients.
Ballantyne CM; Corsini A; Davidson MH; Holdaas H; Jacobson TA; Leitersdorf E; März W; Reckless JP; Stein EA
Arch Intern Med; 2003 Mar; 163(5):553-64. PubMed ID: 12622602
[TBL] [Abstract][Full Text] [Related]
26. [The combinations of statins and fibrates: pharmacokinetic and clinical implications].
González Santos P
Clin Investig Arterioscler; 2014 Jul; 26 Suppl 1():7-11. PubMed ID: 25043540
[TBL] [Abstract][Full Text] [Related]
27. Rhabdomyolysis and HMG-CoA reductase inhibitors.
Omar MA; Wilson JP; Cox TS
Ann Pharmacother; 2001 Sep; 35(9):1096-107. PubMed ID: 11573861
[TBL] [Abstract][Full Text] [Related]
28. Lipid lowering inefficacy of high-dose statin therapy due to concurrent use of phenytoin.
Khandwala HM
South Med J; 2006 Dec; 99(12):1385-7. PubMed ID: 17233196
[TBL] [Abstract][Full Text] [Related]
29. Rhabdomyolysis with HMG-CoA reductase inhibitors and gemfibrozil combination therapy.
Chang JT; Staffa JA; Parks M; Green L
Pharmacoepidemiol Drug Saf; 2004 Jul; 13(7):417-26. PubMed ID: 15269925
[TBL] [Abstract][Full Text] [Related]
30. Review of side-effect profile of combination ezetimibe and statin therapy in randomized clinical trials.
Kashani A; Sallam T; Bheemreddy S; Mann DL; Wang Y; Foody JM
Am J Cardiol; 2008 Jun; 101(11):1606-13. PubMed ID: 18489938
[TBL] [Abstract][Full Text] [Related]
31. Treatment Options for Statin-Associated Muscle Symptoms.
Laufs U; Scharnagl H; Halle M; Windler E; Endres M; März W
Dtsch Arztebl Int; 2015 Oct; 112(44):748-55. PubMed ID: 26575138
[TBL] [Abstract][Full Text] [Related]
32. Statin myopathy: the iceberg or its tip?
Campbell WW
Muscle Nerve; 2006 Oct; 34(4):387-90. PubMed ID: 16810688
[No Abstract] [Full Text] [Related]
33. The broad spectrum of statin myopathy: from myalgia to rhabdomyolysis.
Harper CR; Jacobson TA
Curr Opin Lipidol; 2007 Aug; 18(4):401-8. PubMed ID: 17620856
[TBL] [Abstract][Full Text] [Related]
34. Statin safety and drug interactions: clinical implications.
Bottorff MB
Am J Cardiol; 2006 Apr; 97(8A):27C-31C. PubMed ID: 16581325
[TBL] [Abstract][Full Text] [Related]
35. Pharmacogenetics and pharmacogenomics of cholesterol-lowering therapy.
Schmitz G; Schmitz-Madry A; Ugocsai P
Curr Opin Lipidol; 2007 Apr; 18(2):164-73. PubMed ID: 17353665
[TBL] [Abstract][Full Text] [Related]
36. Monotherapy vs combination therapy for dyslipidemia in the elderly.
Shepherd J
Am J Geriatr Cardiol; 2008; 17(2):108-13. PubMed ID: 18326949
[TBL] [Abstract][Full Text] [Related]
37. A clinician's guide to statin drug-drug interactions.
Kellick KA; Bottorff M; Toth PP; The National Lipid Association's Safety Task Force
J Clin Lipidol; 2014; 8(3 Suppl):S30-46. PubMed ID: 24793440
[TBL] [Abstract][Full Text] [Related]
38. Systematic review: comparative effectiveness and harms of combination therapy and monotherapy for dyslipidemia.
Sharma M; Ansari MT; Abou-Setta AM; Soares-Weiser K; Ooi TC; Sears M; Yazdi F; Tsertsvadze A; Moher D
Ann Intern Med; 2009 Nov; 151(9):622-30. PubMed ID: 19884623
[TBL] [Abstract][Full Text] [Related]
39. Statin-fibrate combination therapy.
Shek A; Ferrill MJ
Ann Pharmacother; 2001; 35(7-8):908-17. PubMed ID: 11485144
[TBL] [Abstract][Full Text] [Related]
40. Safety issues with statin therapy.
Talbert RL
J Am Pharm Assoc (2003); 2006; 46(4):479-88; quiz 488-90. PubMed ID: 16913392
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
